Therapeutics inc therapeutic advancements in San Diego, California

Therapeutics Inc. is a leading healthcare institution located at 9025 Balboa Avenue in San Diego, California. Our team of dedicated doctors and healthcare professionals are committed to providing high-quality, personalized care to each and every patient. From preventative screenings to advanced treatment options, we offer a wide range of services to meet your healthcare needs. Visit us today and experience the difference at Therapeutics Inc. in San Diego.

ProSciento, Inc. is a leading clinical research organization located at 855 3rd Avenue, Chula Vista, California, United States. We specialize in improving the lives of patients with metabolic diseases such as diabetes, NASH, and obesity. Our team of science-driven experts is dedicated to advancing research and therapeutic development in these areas. At ProSciento, we offer a range of services including participant feasibility studies, direct patient engagement, and advanced methodologies to support our clients' commitment to improving human health. Our deep connections with clients and partners, along with our global operations exclusively focused on metabolic diseases, set us apart as a leader in the field.

Kura Oncology, Inc. is a biotechnology company located at 12730 High Bluff Drive in San Diego, California, United States. The company is focused on developing precision medicines to improve the lives of cancer patients. Their innovative therapies target cancer cells specifically, aiming to increase clinical benefit and address areas of high unmet medical need. Kura Oncology is dedicated to discovering and developing novel cancer therapeutics to enhance patient outcomes and expand the number of patients who can benefit from treatment. One of the clinical trials conducted by Kura Oncology is KOMET-007, which involves testing their menin inhibitor, ziftomenib, in combination with standard treatments for acute myeloid leukemia (AML) in patients with specific genetic mutations. The company's mission is to pioneer new approaches in cancer treatment by understanding the molecular processes driving the disease and exploring innovative combinations of therapies to improve long-term remission rates.